Effects of next-generation, dual-active-ingredient, long-lasting insecticidal net deployment on insecticide resistance in malaria vectors in Tanzania: an analysis of a 3-year, cluster-randomised controlled trial.

Autor:	Messenger LA; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; Department of Environmental and Occupational Health, School of Public Health, University of Nevada, Las Vegas, NV, USA; Parasitology and Vector Biology Laboratory, School of Public Health, University of Nevada, Las Vegas, NV, USA. Electronic address: louisa.messenger@unlv.edu., Matowo NS; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK., Cross CL; Parasitology and Vector Biology Laboratory, School of Public Health, University of Nevada, Las Vegas, NV, USA; Department of Epidemiology and Biostatistics, School of Public Health, University of Nevada, Las Vegas, NV, USA., Jumanne M; National Institute for Medical Research, Mwanza Medical Research Centre, Mwanza, Tanzania., Portwood NM; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; Parasitology Unit, Universitätsklinikum Heidelberg, Heidelberg, Germany., Martin J; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; National Institute for Medical Research, Mwanza Medical Research Centre, Mwanza, Tanzania; Kilimanjaro Christian Medical University College, Moshi, Tanzania., Lukole E; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; National Institute for Medical Research, Mwanza Medical Research Centre, Mwanza, Tanzania., Mallya E; National Institute for Medical Research, Mwanza Medical Research Centre, Mwanza, Tanzania., Mosha JF; National Institute for Medical Research, Mwanza Medical Research Centre, Mwanza, Tanzania., Kaaya R; Kilimanjaro Christian Medical University College, Moshi, Tanzania., Moshi O; Kilimanjaro Christian Medical University College, Moshi, Tanzania., Pelloquin B; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan., Fullerton K; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK., Manjurano A; National Institute for Medical Research, Mwanza Medical Research Centre, Mwanza, Tanzania., Mosha FW; Kilimanjaro Christian Medical University College, Moshi, Tanzania., Walker T; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; School of Life Sciences, University of Warwick, Coventry, UK., Rowland M; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK., Kulkarni MA; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada., Protopopoff N; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
Jazyk:	angličtina
Zdroj:	The Lancet. Planetary health [Lancet Planet Health] 2023 Aug; Vol. 7 (8), pp. e673-e683.
DOI:	10.1016/S2542-5196(23)00137-7
Abstrakt:	Background: Insecticide resistance among malaria-vector species is a pervasive problem that might jeopardise global disease-control efforts. Novel vector-control tools with different modes of action, including long-lasting insecticidal nets (LLINs) incorporating new active ingredients, are urgently needed to delay the evolution and spread of insecticide resistance. We aimed to measure phenotypic and genotypic insecticide-resistance profiles among wild Anopheles collected over 3 years to assess the longitudinal effects of dual-active-ingredient LLINs on insecticide resistance. Methods: For this analysis, data nested in a 3-year, four parallel-arm, superiority cluster-randomised controlled trial (cRCT) in Tanzania, collected from 84 clusters (39 307 households) formed of 72 villages in the Misungwi district, were used to measure insecticide-resistance profiles among female Anopheles mosquitoes via insecticide-resistance bioassays and quantitative RT-PCR of metabolic-resistance genes. Wild, blood-fed, indoor-resting mosquitoes were collected annually during the rainy seasons from house walls in clusters from all four trial groups. Mosquitoes were morphologically identified as An gambiae sensu lato (SL) or An funestus SL before separate bioassay testing. The primary outcomes were lethal-dose values for α-cypermethrin, permethrin, and piperonyl butoxide pre-exposure plus permethrin-resistance intensity bioassays, mortality 72 h after insecticidal exposure for chlorfenapyr bioassays, fertility reduction 72 h after insecticidal exposure for pyriproxyfen bioassays, and fold change in metabolic-enzyme expression relative to an insecticide-susceptible laboratory strain. All primary outcomes were measured in An funestus SL 1 year, 2 years, and 3 years after LLIN distribution. Primary outcomes were also assessed in An gambiae SL if enough mosquitoes were collected. The cRCT is registered with ClinicalTrials.gov (NCT03554616). Findings: Between May 24, 2019, and Oct 25, 2021, 47 224 female Anopheles were collected for resistance monitoring. In the pyrethroid (PY)-LLIN group, there were significant increases in α-cypermethrin-resistance intensity (year 1 LD50=9·52 vs year 2 76·20, p<0·0001) and permethrin-resistance intensity (year 1 13·27 vs year 2 35·83, p=0·0019) in An funestus SL. In the pyriproxyfen PY-LLIN group, there was similar increase in α-cypermethrin-resistance intensity (year 1 0·71 vs year 2 81·56, p<0·0001) and permethrin-resistance intensity (year 1 5·68 vs year 2 50·14, p<0·0001). In the piperonyl butoxide PY-LLIN group, α-cypermethrin-resistance intensity (year 1 33·26 vs year 3 70·22, p=0·0071) and permethrin-resistance intensity (year 1 47·09 vs year 3 2635·29, p<0·0001) also increased over time. In the chlorfenapyr PY-LLIN group, there were no effects on α-cypermethrin-resistance intensity (year 1 0·42 vs year 3 0·99, p=0·54) or permethrin-resistance intensity (data were not estimable due to nearly 100% mortality). There were also minimal reductions in chlorfenapyr susceptibility. However, in the chlorfenapyr PY-LLIN group, a significant decline in piperonyl-butoxide synergy was seen by year 3 (year 1 0·02 vs year 3 0·26, p=0·020). Highly over-expressed detoxification enzymes showed dynamic patterns of selection throughout the trial. Interpretation: Our phenotypic data supports trial epidemiological findings; chlorfenapyr PY-LLINs provided superior protection from malaria across multiple transmission seasons, with few effects on insecticide-resistance selection. Rapid pyrethroid-resistance intensification in the piperonyl butoxide PY-LLIN group and pre-existing tolerance of pyriproxyfen in vector populations might explain the poorer performance of these two interventions regarding malaria outcomes. Further work is required to elucidate the potential mechanisms driving cross-resistance between pyrethroids and novel active ingredients to better inform the design of pre-emptive resistance-management strategies. Funding: UK Department for International Development; UK Medical Research Council; Wellcome Trust; UK Department of Health and Social Care; UK Foreign, Commonwealth and Development Office; and The Bill and Melinda Gates Foundation via the Innovative Vector Control Consortium. Competing Interests: Declaration of interests We declare no competing interests. (Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu